Mr David Bath
Research Fellow in Health Economics
I joined the Department of Global Health and Development as a Research Fellow in Health Economics in January 2015, after completing an MSc in Public Health at LSHTM. I also have a Masters in Applied Finance from Macquarie University and a BA in Political Science from The University of Western Australia.
Prior to LSHTM, I worked in health consulting in Australia, advising on large-scale health system reform and health infrastructure projects.
I am a seminar leader on the Term 2 module Economic Evaluation, having previously taught for many years on the Economic Evaluation distance learning module. I have also been a seminar leader on the Term 1 module Introduction to Health Economics and lectured on the Epidemiology and Control of Malaria module.
I am a personal tutor and summer project supervisor for students on the MSc Public Health.
My primary research focuses on applied economic evaluations of malaria control interventions. I am currently the health economist on the SMC Impact project, modelling the effectiveness and cost-effectiveness of adding an additional month of seasonal malaria chemoprevention and/or increasing SMC to older children (5-10 years), in areas of seasonal malaria transmission in Guinea, Mali, and Niger. I am also part of the Resiliance Against Future Threats through Vector Control (RAFT) project, developing methods to improve economic evaluations of vector control interventions and assist decision-makers in making choices about intervention packages across heterogeneous geography/populations to maximise the health impact of scarce health resources.
Other recent projects include cost-effectiveness modelling of the introduction of malaria rapid diagnostic tests in the private retail sector in sub-Saharan Africa, and economic evaluations alongside: a cluster-randomised trial of reactive malaria case detection in Cambodia, a cluster-randomised trial of a novel long-lasting insecticidal net against malaria in Tanzania, and a cluster-randomised non-inferiority trial of targeted malaria vector control in South Africa. I was also the health economist on the PERFORM study, a large EU Horizon 2020 project across 12 sites in 8 countries, evaluating the cost-effectiveness of a new diagnostic test to improve management of febrile illness in children.